NDC 67386-130 – Vyepti
Eptinezumab 100 mg/mL · Injection · Intravenous
Product NDC67386-130
Product details
- Brand name
- Vyepti
- Generic name
- Eptinezumab-jjmr
- Labeler
- Lundbeck Pharmaceuticals LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761119
- Marketed since
- February 21, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Calcitonin Gene-related Peptide Antagonist
Active ingredients
- Eptinezumab 100 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 67386-130-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51) / 1 mL in 1 VIAL, SINGLE-DOSE | Feb 21, 2020 |
| 67386-130-91 sample | 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1 VIAL, SINGLE-DOSE | Apr 1, 2023 |